Aligos Therapeutics Inc
NASDAQ:ALGS

Watchlist Manager
Aligos Therapeutics Inc Logo
Aligos Therapeutics Inc
NASDAQ:ALGS
Watchlist
Price: 19.46 USD -0.61% Market Closed
Market Cap: 120m USD
Have any thoughts about
Aligos Therapeutics Inc?
Write Note

Aligos Therapeutics Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Aligos Therapeutics Inc
Total Equity Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Aligos Therapeutics Inc
NASDAQ:ALGS
Total Equity
$92.1m
CAGR 3-Years
-25%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Equity
$6B
CAGR 3-Years
-24%
CAGR 5-Years
N/A
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
Total Equity
$18.4B
CAGR 3-Years
-5%
CAGR 5-Years
-2%
CAGR 10-Years
3%
Amgen Inc
NASDAQ:AMGN
Total Equity
$7.5B
CAGR 3-Years
-3%
CAGR 5-Years
-7%
CAGR 10-Years
-11%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Equity
$15.6B
CAGR 3-Years
18%
CAGR 5-Years
24%
CAGR 10-Years
30%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Equity
$29.3B
CAGR 3-Years
19%
CAGR 5-Years
23%
CAGR 10-Years
28%

See Also

What is Aligos Therapeutics Inc's Total Equity?
Total Equity
92.1m USD

Based on the financial report for Dec 31, 2023, Aligos Therapeutics Inc's Total Equity amounts to 92.1m USD.

What is Aligos Therapeutics Inc's Total Equity growth rate?
Total Equity CAGR 5Y
1%

Over the last year, the Total Equity growth was -11%. The average annual Total Equity growth rates for Aligos Therapeutics Inc have been -25% over the past three years , 1% over the past five years .

Back to Top